Thus, this retrospective cohort study was conducted to assess the prognostic significance of plasmatic levels of HSP90α at diagnosis in advanced lung cancer patients treated with PD-1/PD-L1 inhibitors plus chemotherapy. This evidence concerns the gene HSP90AA1 and lung cancer.